← FDA DRUG APPROVALS

FDA ANDA · ANDA074465

TIMOLOL MALEATE

Sponsor: EPIC PHARMA LLC

APPLICATION
ANDA074465
TYPE
ANDA
ORIGINAL APPROVAL
1997-03-25
LATEST ACTION
2020-09-30
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued

Products

TIMOLOL MALEATEDiscontinued
TIMOLOL MALEATE EQ 0.25% BASE · SOLUTION/DROPS · OPHTHALMIC

Approval history

2020-09-30Labeling · Supplement 6 · standardAP
2000-10-27Manufacturing (CMC) · Supplement 3AP
1999-01-25Labeling · Supplement 2AP
1998-02-12Labeling · Supplement 1AP
1997-03-25OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →